Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1991 Oct;74(2):223–227.

Carrier-induced suppression of the antibody response to a 'self' hapten.

S Sad 1, H M Gupta 1, G P Talwar 1, R Raghupathy 1
PMCID: PMC1384596  PMID: 1748470

Abstract

Immunization of male rats and monkeys with gonadotropin-releasing hormone (GnRH) conjugated to a carrier results in a dramatic atrophy of the prostate. GnRH, linked to either diphtheria toxoid or tetanus toxoid as carrier, is now being evaluated for its use in the immunotherapy of hormone-dependent prostate enlargement in men. This report deals with the phenomenon of carrier-induced, epitope-specific regulation in the GnRH-carrier system. In experiments designed to assess the influence of the carrier on antibody responses to the 'self' hapten GnRH, we show that preimmunization with carriers diphtheria toxoid and tetanus toxoid results in a strain-dependent inhibition of anti-GnRH responses in mice. Results of adoptive transfer experiments indicate that T cells from carrier-presensitized mice are responsible for suppression of anti-haptenic antibodies and that T cells from conjugate-immunized mice, on the other hand, can actually help overcome hyporesponsiveness.

Full text

PDF
227

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avrameas S. Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies. Immunochemistry. 1969 Jan;6(1):43–52. doi: 10.1016/0019-2791(69)90177-3. [DOI] [PubMed] [Google Scholar]
  2. Etlinger H. M., Felix A. M., Gillessen D., Heimer E. P., Just M., Pink J. R., Sinigaglia F., Stürchler D., Takacs B., Trzeciak A. Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, Plasmodium falciparum. J Immunol. 1988 Jan 15;140(2):626–633. [PubMed] [Google Scholar]
  3. Etlinger H. M., Gillessen D., Lahm H. W., Matile H., Schönfeld H. J., Trzeciak A. Use of prior vaccinations for the development of new vaccines. Science. 1990 Jul 27;249(4967):423–425. doi: 10.1126/science.1696030. [DOI] [PubMed] [Google Scholar]
  4. Giri D. K., Chaudhuri M. K., Jayashankar R., Neelaram G. S., Jayaraman S., Talwar G. P. Histopathological changes in reproductive organs of male Wistar rats following active immunization against LHRH. Exp Mol Pathol. 1990 Feb;52(1):54–62. doi: 10.1016/0014-4800(90)90058-l. [DOI] [PubMed] [Google Scholar]
  5. Herzenberg L. A., Tokuhisa T. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses. J Exp Med. 1982 Jun 1;155(6):1730–1740. doi: 10.1084/jem.155.6.1730. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Herzenberg L. A., Tokuhisa T., Hayakawa K. Epitope-specific regulation. Annu Rev Immunol. 1983;1:609–632. doi: 10.1146/annurev.iy.01.040183.003141. [DOI] [PubMed] [Google Scholar]
  7. Herzenberg L. A., Tokuhisa T., Parks D. R., Herzenberg L. A. Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memory. J Exp Med. 1982 Jun 1;155(6):1741–1753. doi: 10.1084/jem.155.6.1741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jayashankar R., Chaudhuri M. K., Singh O., Alam A., Talwar G. P. Semisynthetic anti-LHRH vaccine causing atrophy of the prostate. Prostate. 1989;14(1):3–11. doi: 10.1002/pros.2990140103. [DOI] [PubMed] [Google Scholar]
  9. Jeffcoate S. L., Flaser H. M., Holland D. T., Gunn A. Radioimmunoassay of luteinizing hormone-releasing hormone (LH-RH) in serum from man, sheep and rat. Acta Endocrinol (Copenh) 1974 Apr;75(4):625–635. doi: 10.1530/acta.0.0750625. [DOI] [PubMed] [Google Scholar]
  10. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  11. Lise L. D., Mazier D., Jolivet M., Audibert F., Chedid L., Schlesinger D. Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier. Infect Immun. 1987 Nov;55(11):2658–2661. doi: 10.1128/iai.55.11.2658-2661.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sad S., Talwar G. P., Raghupathy R. Influence of the genetic background and carrier protein on the antibody response to GnRH. J Reprod Immunol. 1991 Feb;19(2):197–207. doi: 10.1016/0165-0378(91)90017-k. [DOI] [PubMed] [Google Scholar]
  13. Schutze M. P., Deriaud E., Przewlocki G., LeClerc C. Carrier-induced epitopic suppression is initiated through clonal dominance. J Immunol. 1989 Apr 15;142(8):2635–2640. [PubMed] [Google Scholar]
  14. Schutze M. P., Leclerc C., Jolivet M., Audibert F., Chedid L. Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J Immunol. 1985 Oct;135(4):2319–2322. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES